CLINICS 2012;67(6):615-621 20. Standardization of spirometry-1987 update. Statement of the American Thoracic Society. Am Rev Respir Dis. 1987;136:1285-98, http:// dx.doi.org/10.1164/ajrccm/136.5.1285. 21. Crapo RA, Morris AH, Gardner RM. References spirometric values using techniques and equipment that meet ATS recommendations. Am Rev Respir Dis. 1981;123(6):659-64. 22. Crapo RO, Morris AH, Clayton PD, Nixon CR. Lung volumes in healthy nonsmoking adults. Bull Eur Physiopathol Respir. 1982;18(3):419-25. 23. Sociedade Brasileira de Cardiologia. III Guidelines of Sociedade Brasileira de Cardiologia on the exercise test. Arq Bras Cardiol. 2010;95(5 Suppl 1):1-26. 24. Grizzle JE. The two-period cross-over design and its use in clinical trials. Biometrics. 1965;21:467-80, http://dx.doi.org/10.2307/2528104. 25. Hills M, ArmitageP. The two period cross-over clinical trial. Br J Clin Pharmacol. 1979;8(1):7-20. 26. Fergunson G. Why does the lung hyperinflate? Proc Am Thorac Soc. 2006;3(2):176-9, http://dx.doi.org/10.1513/pats.200508-094DO. 27. Spivey MH, Skobeloff EM, Levin RM. Effect of magnesium chloride on rabbit bronchial smooth muscle. Ann Emerg Med. 1990;19(1):1107–12, http://dx.doi.org/10.1016/S0196-0644(05)81513-6. 28. Del Castillo J, Engbauk L. The nature of the neuromuscular block produced by magnesium. J Physiol, 1954;124(2):370-84. 29. Nadler JL, Goodson S, Rude RK. Evidence that prostacyclin mediates the vascular action of magnesium in humans. Hypertension. 1987;9(4):379-83. 30. Kemp PA, Gardiner SM, March JE, Bennett T, Rubin PC. Effects of NG- nitro-L-arginine methyl ester on regional haemodynamic responses to MgSO4 in conscious rats. Br J Pharmacol. 1994;111(1):325-31. 31. Yogi A, Callera GE, Antunes TT, Tostes RC, Touyz RM. Vascular biology of magnesium and its transporters in hypertension. Circ J. 2011;75(2):237- 45, http://dx.doi.org/10.1253/circj.CJ-10-1021. 32. Wukitsch MW, Petterson MT, Tobler DR, Pologe JA. Pulse oximetry: analysis of theory, technology, and practice. J Clin Monit. 1988;4(4):290- 301, http://dx.doi.org/10.1007/BF01617328. 33. O’Donnell DE, Webb KA. The major limitation to exercise performance in COPD is dynamic hyperinflation. J Appl Physiol. 2008;105(2):753-5; discussion 755-7, http://dx.doi.org/10.1152/japplphysiol.90336.2008b. Mg loading and exercise on COPD Amaral AF et al. 34. Laveneziana P, Parker CM, O’Donnell DE. Ventilatory constraints and dyspnea during exercise in chronic obstructive pulmonary disease. Appl Physiol Nutr Metab. 2007;32(6):1225-38, http://dx.doi.org/10.1139/H07- 119. 35. Ofir D, Laveneziana P, Webb KA, Lam YM, O’Donnell DE. Mechanisms of dyspnea during cycle exercise in symptomatic patients with GOLD stage I chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2008;177(6):622-9, http://dx.doi.org/10.1164/rccm.200707- 1064OC. 36. Chen YJ, Chen HY, Wang MF, Hsu MH, Liang WM, Cheng FC. Effects of magnesium on exercise performance and plasma glucose and lactate concentrations in rats using a novel blood-sampling technique. Appl Physiol Nutr Metab. 2009;34(6):1040-7, http://dx.doi.org/10.1139/H09- 105. 37. Cheng SM, Yang DY, Lee CP, Pan HC, Lin MT, Chen SH, et al. Effects of magnesium sulfate on dynamic changes of brain glucose and its metabolites during a short-term forced swimming in gerbils. Eur J Appl Physiol. 2007;99(6):695-9. 38. Cheng SM, Yang LL, Chen SH, Hsu MH, Chen IJ, Cheng FC. Magnesium sulfate enhances exercise performance and manipulates dynamic changes in peripheral glucose utilization. Eur J Appl Physiol. 2010;108(2):363-9. 39. Cinar V, Mogulkoc R, Baltaci AK, Polat Y. Adrenocorticotropic hormone and cortisol levels in athletes and sedentary subjects at rest and exhaustion:effects of magnesium supplementation. Biol Trace Elem Res. 2008;121(3):215-20, http://dx.doi.org/10.1007/s12011-007-8052-0. 40. Mooren FC, Golf SW, Lechtermann A, V o¨ler K. Alterations of ionized Mg2+ in human blood after exercise. Life Sci. 2005;77(11): 1211-25, http:// dx.doi.org/10.1016/j.lfs.2004.12.040. 41. Fuentes JC, Salmon AA, Silver MA. Acute and chronic oral magnesium supplementation: effects on endothelial function, exercise capacity, and quality of life in patients with symptomatic heart failure. Congest Heart Fail. 2006;12(1):9-13, http://dx.doi.org/10.1111/j.1527-5299.2006.04692.x. 42. Shechter M, Sharir M, Labrador MJ, Forrester M, Silver B, Bairey Merz CN. Oral magnesium therapy improves endothelial function in patients with coronary artery disease. Circulation. 2000;102(19):2353-8. 621